Without seeing the full landscape and all potential targets, nothing can stick," explains Dr. Concorde. UPmedicine TI is groundbreaking in its approach to deploying science within complex, real-world contexts. "The highest-level difference lies in how we envisage a disease – or an individual's presentation of it – and how much science we can thereby apply." "Crucially, UPmedicine TI has developed the art of generating new knowledge – knowledge not yet known – which emanates from all science. This provides greater 'sight,' and means our translations incorporate more science," says Dr. Alex. Oonah Buist adds, "Like a highly-skilled pilot in clear weather with superior visual aids, making drops of medical supplies direct to hospitals, not through dense fog and without GPS, hoping none of them land on a beach party." The Foundation: XLII® – Three Decades in the Making The overarching platform – a ‘meta’ innovation - is a pivotal strategic progression called 'XLII®'. It provides the know-how for leveraging science in a ‘gainful’ way, and the ‘intuitive intelligence’ for generating new knowledge. The means for creating meaningful gains from complexity is crucial to working entire resources of empirical science. Health and Disease as Dynamic, Complex Systems Dr. Concorde explains, “Science has reached a pinnacle, revealing an undeniable truth: human health is shaped by a complex, multidimensional, intricate interplay of factors. Deviations from optimal health, when examined intuitively, empirically, and through the lens of meaningful individual utility, expose underlying patterns. Disease emerges from webs of determinants, defying traditional oversimplifications. Crucially, the essence of disease lies in the interconnections and interactions among factors, driving outcomes in seemingly unpredictable ways.” Finding the Order in Chaos and Complexity UPmedicine TI’s groundbreaking capabilities align with modern perspectives on chaos theory. Oonah Buist says, “Finding order in chaos once seemed like an oxymoron. Chaos theory was thought to deal with random disorder, grounded in the notion of indecipherable states. However, it is now known that chaos is multi-determinate. The challenge lies in identifying the determinants at play. Chaos represents complexity that extends beyond what most can perceive. Yet is far from truly chaotic - there are underlying patterns, even in constantly-shifting states. It’s not that cause and effect don’t exist; rather, there are so many interconnected ‘causes’ and so many nuanced effects that they can overwhelm the capacity to grasp them. We need ‘special’ intelligence to do so.” The ARC Thesis®: A Transformative New Paradigm for Cancer One key re-conceptualization is cancer. Cancer, long perceived as a slayable "foreign enemy", is now understood to be a dynamic entity, hardwired within us, deeply integrated into normal body systems. It’s not discrete, nor discontinuous, and actually: you. UPmedicine TI’s ARC Thesis® (Activated Regression of Cancer) advances insights that cancer can regress from ‘undeniably cancer’ towards, or even to, ‘normal’, until its final, irreversible stages – a seismic shift for the entire landscape. Firstly, if cancer remains tethered to normalcy, and regression progressed, there is gain in the individual’s net health, plus net cost to the cancer. Secondly, the less a cancer deviates from normal, the more tolerable precision oncological treatments can be, at less toxic doses - so more anti-cancer gains at lower cost to health. On both accounts: exponential gains and lower risks to life. This radically reimagines the future and flips the current paradigm on its head. Harnessing Science to Target Cancer in an Entirely Individual Way Using the XLII® framework, established and emerging science, UPmedicine TI has elucidated precise avenues for steering cancer toward normalcy while restoring hijacked individual systems. Coincidentally, we can now map an individual’s cancer with unprecedented exactitude – tracing its genomic, proteomic, and metabolic profiles alongside other tumour and personal data. Most of this data remains therapeutically untapped outside of possibilities within the ARC Paradigm® and could never be utilised ‘en masse’ (i.e., with target multiplicity) by any other system of our time. Bold Innovation for a New Era of Medicine This illustrates how UPmedicine TI’s capabilities provide a new paradigm for transforming unharnessed science into translational and clinical gains. Innovations are ‘totality of science’ led – with UPmedicine TI working beyond outdated models and frameworks, using science to reveal a disease’s composition and M.O., and generating ultra-personalized, precision propositions with unmatched data specificity. As Oonah Buist says, "For small steps, colour nicely within the given lines, but radical innovation demands intelligent disruption of the expected. It requires us to question the lines themselves and the very essence of colour and art. " XLII® thinking redefines how we understand diseases and can transform known data into new knowledge. In personalized medicine, Translational Intelligence® unlocks potential for immediate, actionable gains, targeting the precise factors relevant to an individual’s condition. UPmedicine TI is a strategic innovator, recognised for its leadership in Translational Medicine. Company: UPmedicine TI Ltd Name: Dr Alex Concorde & Oonah Buist Email: contact@UPmedicineTI.com Web Address: UPMedicineTI.com
RkJQdWJsaXNoZXIy NTY1MjM3